We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+20.93%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$237B
AUM Growth
+$24.6B
Cap. Flow
-$17.5B
Cap. Flow %
-7.37%
Top 10 Hldgs %
15.61%
Holding
8,813
New
706
Increased
2,953
Reduced
4,001
Closed
776

Sector Composition

Rank Sector Weight
1 Technology 10.78%
2 Healthcare 6.25%
3 Consumer Discretionary 6.24%
4 Financials 5.99%
5 Communication Services 4.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WTV icon
5051
WisdomTree US Value Fund
WTV
$3.36B
$142K ﹤0.01%
+3,616
New +$135K
BWIN
5052
Baldwin Insurance Group
BWIN
$2.79B
$142K ﹤0.01%
8,169
-4,403
-35% -$53.1K
FRLG
5053
DELISTED
Large Cap Growth Index-Linked Exchange Traded Notes due 2028
FRLG
$142K ﹤0.01%
919
-486
-35% -$65K
QEP
5054
DELISTED
QEP RESOURCES, INC.
QEP
$142K ﹤0.01%
109,869
-668,511
-86% -$624K
BHVN
5055
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$142K ﹤0.01%
1,943
+795
+69% +$42.3K
CAMT icon
5056
Camtek
CAMT
$7.38B
$141K ﹤0.01%
11,228
+755
+7% +$8.58K
QED
5057
DELISTED
IQ Hedge Event-Driven Tracker ETF
QED
$141K ﹤0.01%
6,474
+6,346
+4,958% +$134K
CHA
5058
DELISTED
China Telecom Corporation, LTD
CHA
$141K ﹤0.01%
5,045
+401
+9% +$12.7K
MNTA
5059
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$140K ﹤0.01%
4,215
-29,809
-88% -$949K
CELC icon
5060
Celcuity
CELC
$4.43B
$139K ﹤0.01%
20,000
-2,955
-13% -$20.8K
TCX icon
5061
Tucows
TCX
$143M
$139K ﹤0.01%
2,429
-3,966
-62% -$220K
SYRS
5062
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$139K ﹤0.01%
1,301
-373
-22% -$33.5K
FMAO icon
5063
Farmers & Merchants Bancorp
FMAO
$473M
$138K ﹤0.01%
6,502
-3,764
-37% -$83.2K
GTX icon
5064
Garrett Motion
GTX
$5.41B
$138K ﹤0.01%
24,995
+5,746
+30% +$28.1K
KBWP icon
5065
Invesco KBW Property & Casualty Insurance ETF
KBWP
$270M
$138K ﹤0.01%
2,466
-928
-27% -$50.1K
NTCT icon
5066
NETSCOUT
NTCT
$2.81B
$138K ﹤0.01%
5,373
-44,650
-89% -$1.15M
ODC icon
5067
Oil-Dri
ODC
$1.28B
$138K ﹤0.01%
7,934
+182
+2% +$3.15K
OTRK
5068
DELISTED
Ontrak
OTRK
$138K ﹤0.01%
62
-23
-27% -$46.1K
PMT
5069
PennyMac Mortgage Investment
PMT
$818M
$138K ﹤0.01%
7,877
-21,699
-73% -$260K
URTY icon
5070
ProShares UltraPro Russell2000
URTY
$351M
$138K ﹤0.01%
4,249
+2,625
+162% +$70.8K
LORL
5071
DELISTED
Loral Space and Communications, Inc.
LORL
$138K ﹤0.01%
7,088
+1,178
+20% +$22.1K
KRO icon
5072
KRONOS Worldwide
KRO
$977M
$137K ﹤0.01%
13,161
-1,075
-8% -$10.1K
MOFG
5073
DELISTED
MidWestOne Financial Group
MOFG
$137K ﹤0.01%
6,862
-1,478
-18% -$28.5K
PHAT icon
5074
Phathom Pharmaceuticals
PHAT
$693M
$137K ﹤0.01%
4,177
-2,238
-35% -$86K
RFEM icon
5075
First Trust RiverFront Dynamic Emerging Markets ETF
RFEM
$81.3M
$137K ﹤0.01%
+2,465
New +$129K

Similar funds

UBS Group's Q2 2020 Portfolio in Review

As of Q2 2020, UBS Group held 8,813 positions worth $237B, up 12% from $212B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group withdrew a net $17.5B in Q2 2020, closing 776 positions and reducing 4,001 holdings. Its most notable exit was Allergan plc, an estimated $1.21B position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, UBS Group opened a new position in Warner Music worth $87.9M.

  • UBS Group's largest Q2 2020 buy was Warner Music: 2,981,053 shares worth $87.9M.
  • UBS Group added most to Vanguard Morningstar Mid-Cap ETF in Q2 2020, an estimated $511M increase.
  • UBS Group's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.14B.
  • UBS Group fully exited Allergan plc in Q2 2020, selling an estimated $1.21B.
  • UBS Group's ten largest holdings make up 16% of its $237B portfolio in Q2 2020.
  • UBS Group opened 706 new positions and closed 776 in Q2 2020.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $237B.

Based on UBS Group's 13F filing for Q2 2020, filed 31 Jul 2020.